Log in to search using one of your social media accounts:

Working memory capacity is equally unrelated to auditory distraction by changing-state and deviant sounds

Publication date: October 2017 Source:Journal of Memory and Language, Volume 96 Author(s): Ulrike Körner, Jan P. Röer, Axel Buchner, Raoul Bell The duplex-mechanism account states that there are two fundamentally different types of auditory distraction. The disruption by a sequence of changing auditory distractors (the changing-state effect) is attributed to the obligatory processing of the to-be-ignored information, which automatically interferes with short-term memory. The disruption by a sequence with a single deviant auditory distractor (the deviation effect), in contrast, is attributed to attentional capture. This account predicts that working memory capacity (WMC) is differentially related to the changing-state effect and to the deviation effect: The changing-state effect is assumed to be immune to cognitive control and, thus, to be unrelated to WMC. The deviation effect, in contrast, is assumed to be open to cognitive control and, thus, to be negatively related to WMC. Despite several methodological improvements over previous studies (large sample sizes, a composite measure of WMC, and a direct statistical comparison of the correlations), there was no evidence of a dissociation between the changing-state effect and the deviation effect. WMC was unrelated both to the size of the changing-state effect and to the size of the deviation effect, irrespective of whether simple stimuli (letters, Experiments 1 and 3) or complex stimuli (words and sentences, Experimen...
Source: Journal of Memory and Language - Category: Speech-Language Pathology Source Type: research

Related Links:

Thymic carcinomas are rare malignant tumors, located in the anterior mediastinum. For the treatment of these carcinomas, several chemotherapy regimens have been suggested, including carboplatin plus paclitaxel. However, because of the rarity of these tumors, the standard chemotherapy regimen has not yet been established. Here, we report a case of thymic carcinoma that responded to first-line carboplatin plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) therapy with continuation maintenancenab-paclitaxel monotherapy. A 78-year-old male presented to a hospital with the chief complaint of dyspnea. Cardiomegaly was d...
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
In this report, we present an 18-year-old male patient with pulmonary vein leiomyosarcoma in whom the use of paclitaxel (PAX) proved to be effective. Because the tumor originated from the left superior pulmonary vein and diffused into the left atrial wall and the junction of the right superior pulmonary vein and left atrium, the en bloc excision of the tumor was impossible. The first-line chemotherapy, including ifosfamide, doxorubicin, and dacarbazine, in conjugation with radiation therapy could not demonstrate any effect on the tumor size. However, the following PAX-containing regimen provided complete regression of the ...
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
Objective: The present study evaluated the clinical relevance of an integrative preoperative assessment of inflammation-, nutrition-, and muscle-based markers for patients with muscle-invasive bladder cancer (MIBC) undergoing curative radical cystectomy (RC).Methods: The analysis enrolled 117 patients and the variables included age, body mass index (BMI), neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, modified Glasgow Prognostic Score (mGPS), prognostic nutritional index (PNI), Controlling Nutritional Status score, psoas muscle index (PMI), and peak expiratory flow (PEF). The co...
Source: Oncology - Category: Cancer & Oncology Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Article Source Type: research
More News: Speech-Language Pathology | Statistics | Study